Topic

thyroid

4 articles

FDA Class I thyroid recall covers 1,955 bottles: UAE pharmacies should check Lot 504950

Vitruvias recalled one lot of 30 mg thyroid tablets after superpotency testing. UAE clinics and insurers should audit dispensing records and patient queries.

27 Sept 2026 · 3 min read

FDA Class I thyroid recall covers 1,955 bottles: UAE pharmacies should check Lot 504950

FDA thyroid recall affects 1,955 units: what Dubai pharmacies should check first

How a U.S. thyroid recall can reach Dubai patients through imported stock, travel and switching. Who is at risk, and what operators should verify.

25 Sept 2026 · 3 min read

FDA thyroid recall affects 1,955 units: what Dubai pharmacies should check first

Breaking

FDA puts 1 Vitruvias thyroid lot at Class I risk, forcing UAE pharmacy checks

The FDA raised one Vitruvias thyroid-tablet recall to Class I. UAE clinics and insurers should check stock, substitutions and thyroid-test access.

25 Sept 2026 · 3 min read

FDA puts 1 Vitruvias thyroid lot at Class I risk, forcing UAE pharmacy checks

FDA recalls 3,655 Vitruvias thyroid tablet units: UAE pharmacies should check Lot 504950

The FDA recall covers one US-distributed thyroid tablet lot. UAE clinics and insurers should check imported stock, substitutions and patient advice.

28 Aug 2026 · 3 min read

FDA recalls 3,655 Vitruvias thyroid tablet units: UAE pharmacies should check Lot 504950